Leslie's, Inc.
Leslie's, Inc. (LESL) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Leslie's, Inc. (LESL), covering cash flow, earnings, and balance sheets.
Leslie's, Inc. (LESL) Income Statement & Financial Overview
Review Leslie's, Inc. LESL income statement with detailed quarterly and annual figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $177.13M | $175.23M | $397.86M | $569.64M |
Cost of Revenue | $133.19M | $127.51M | $254.65M | $340.80M |
Gross Profit | $43.95M | $47.72M | $143.21M | $228.84M |
Gross Profit Ratio | $0.25 | $0.27 | $0.36 | $0.40 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $92.33M | $87.42M | $116.79M | $131.15M |
Operating Expenses | $92.33M | $87.42M | $116.79M | $131.15M |
Total Costs & Expenses | $225.51M | $214.93M | $371.44M | $471.94M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $15.90M | $15.76M | $17.02M | $18.16M |
Depreciation & Amortization | $8.27M | $8.24M | -$1000.00 | $8.25M |
EBITDA | -$40.11M | -$31.46M | $26.42M | $105.94M |
EBITDA Ratio | -$0.23 | -$0.18 | $0.07 | $0.19 |
Operating Income | -$48.38M | -$39.70M | $26.42M | $97.69M |
Operating Income Ratio | -$0.27 | -$0.23 | $0.07 | $0.17 |
Other Income/Expenses (Net) | -$15.90M | -$15.76M | -$17.02M | -$18.16M |
Income Before Tax | -$64.28M | -$55.46M | $9.40M | $79.54M |
Income Before Tax Ratio | -$0.36 | -$0.32 | $0.02 | $0.14 |
Income Tax Expense | -$12.96M | -$10.90M | $19.33M | $18.89M |
Net Income | -$51.32M | -$44.56M | -$9.92M | $60.65M |
Net Income Ratio | -$0.29 | -$0.25 | -$0.02 | $0.11 |
EPS | -$0.28 | -$0.24 | -$0.05 | $0.33 |
Diluted EPS | -$0.28 | -$0.24 | -$0.05 | $0.33 |
Weighted Avg Shares Outstanding | $185.26M | $185.02M | $184.94M | $184.83M |
Weighted Avg Shares Outstanding (Diluted) | $185.26M | $185.02M | $184.94M | $184.86M |
Financial performance has remained strong, with revenue growing from $569.64M in Q3 2024 to $177.13M in Q2 2025. Gross profit continued to perform well, with margins at 25% in the latest quarter. Operating income reached -$48.38M in Q2 2025, holding a steady -27% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$40.11M. Net income dropped to -$51.32M, keeping EPS at -$0.28. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan